<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01392781</url>
  </required_header>
  <id_info>
    <org_study_id>14/1-3-2011</org_study_id>
    <nct_id>NCT01392781</nct_id>
  </id_info>
  <brief_title>Markers and Calculation of Cardiovascular Risk in the Distinct Phenotypes of Polycystic Ovary Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Polycystic ovary syndrome (PCOS) is the most common endocrine disorder and cause of
      anovulatory infertility among reproductive aged women. According to the revised criteria of
      2003, four distinct phenotypes of PCOS can be diagnosed. However, there are emerging evidence
      supporting the existence of different levels of cardiometabolic risk between the four
      phenotypic groups of the syndrome. The purpose of this study is to determine the
      cardiovascular risk of i) normoweight and ii)overweight plus obese women of every one of the
      four phenotypes of the syndrome as well as the levels of low inflammation serum markers and
      the possible correlations of the between the outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>high sensitivity C-Reactive Protein (hsC-RP) levels and differences between the phenotypes</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Lipoprotein-associated phospholipase2 (Lp-PLA2) levels and differences between the phenotypes</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular Risk Assessment and differences between the phenotypes</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>normoweight PCOS patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>normoweight controls</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>overweight plus obese PCOS patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>overwqeight plus obese controls</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatient women with PCOS (normalweight, overweight plus obese) Healthy volunteers
        controls (normalweight, overweight plus obese)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of PCOS (criteria 2003)

          -  Healthy controls

        Exclusion Criteria:

          -  any condition mimicking PCOS

          -  any systematic disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Georgios Daskalopoulos, M.D.</last_name>
    <email>daskalog@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Second Department of Obstetrics and Gynecology, Third Department of Cardiology, Second Propedeutic Department of Internal Medicine, Aristotle University</name>
      <address>
        <city>Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasileios Athyros, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Georgios Daskalopoulos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2011</study_first_submitted>
  <study_first_submitted_qc>July 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2011</study_first_posted>
  <last_update_submitted>July 12, 2011</last_update_submitted>
  <last_update_submitted_qc>July 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2011</last_update_posted>
  <responsible_party>
    <name_title>Daskalopoulos Georgios</name_title>
    <organization>Aristotle University of Thessaloniki</organization>
  </responsible_party>
  <keyword>PCOS</keyword>
  <keyword>hsC-RP</keyword>
  <keyword>Lp-PLA2</keyword>
  <keyword>cardiovascular risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

